Half a decade after receiving a psychedelic treatment for depression, two-thirds of patients in a new study remained in ...

Psilocybin, the active ingredient in magic mushrooms, might just revolutionize how depression and anxiety are treated in ...

David Seymour, New Zealand’s Associate Minister for Health, told reporters that the new policy, which allows a single ...

A pilot study involving psilocybin-assisted therapy found possible antidepressant effects for people with bipolar II disorder ...

New results from a clinical trial reveal that a single dose of psilocybin—a naturally occurring psychedelic compound found in ...

New research shows a single dose leads to 'robust' reductions in depression and anxiety up to 2 years afterward.

Psilocybin, a psychedelic compound once primarily known as a party drug, is increasingly being recognised for its medical ...

A new study from the American Cancer Society’s medical journal found that psilocybin — the active ingredient in “magic ...

The psilocybin found in "magic mushrooms" might be key to quelling depression among people battling cancer, a new study found ...

New research shows psilocybin can produce lasting reductions in depression and anxiety in cancer patients with major ...

New Zealand today approved the medicinal use of psilocybin, a hallucinogenic compound notably found in so-called “magic ...